Jeff Yass’s Jasper Therapeutics JSPR Stock Holding History
Bought
Maintained
Sold
Other funds holding JSPR
OM
ACA
KCM
Jeff Yass's JSPR Position: Q3 2026 in Review
Jeff Yass opened a new position in Jasper Therapeutics (JSPR) in Q3 2026: 1,146 shares worth $19.9K. The stake represents ﹤0.01% of the portfolio and ranks #13126 among its holdings. This is a return to the name: Jeff Yass previously reported a position in JSPR as recently as Q1 2026.
Jeff Yass first reported a position in JSPR in Q4 2022 and has held it in 11 quarters since. The position peaked at $488K in Q4 2024. 50 funds tracked by Wall St. Rank hold JSPR as of Q3 2026.
- Jeff Yass held 1,146 shares of Jasper Therapeutics worth $19.9K as of Q3 2026.
- Jasper Therapeutics was a new Jeff Yass position in Q3 2026.
- Jasper Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #13126 holding.
- Jeff Yass first reported a position in Jasper Therapeutics in Q4 2022 and has held it in 11 quarters since.
- Jeff Yass's Jasper Therapeutics position peaked at $488K in Q4 2024.
- 50 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.